Anaphylaxis associated with intracavernous penile injection of prostaglandin E1 in combination with papaverine and phentolamine
Anafilaxia associada à injeção intracavernosa peniana de prostaglandina E1 em combinação com papaverina e fentolamina
Mario Geller
Abstract
Total radical prostatectomy for advanced prostate cancer may lead to sexual impotence, since it is associated with severe erectile dysfunction. A widely recommended treatment for this disabling condition is intracavernous penile injection of a mixture of prostaglandin E1, papaverine, and phentolamine. To our knowledge, we present the first case of anaphylaxis associated with intracavernous penile injection of prostaglandin E1 in combination with papaverine and phentolamine.
Keywords
Resumo
A prostatectomia radical total para câncer de próstata avançado pode levar à impotência sexual, associada a uma disfunção erétil grave. Um tratamento amplamente recomendado para esta condição incapacitante é a injeção intracavernosa no pênis de uma mistura de prostaglandina E1, papaverina e fentolamina. Até onde sabemos, estamos apresentando o primeiro caso de anafilaxia associada à injeção intracavernosa peniana de prostaglandina E1 em combinação com papaverina e fentolamina.
Palavras-chave
Referências
1. Chandeck Montesa K, Chen Jiménez J, Tamayo JC, Rodríguez Antolín A, Alvarez González E. Prospective study of the effectiveness and side effects of intracavernous prostaglandin E1 versus papaverine or papaverine phentolamine in the diagnosis and treatment of erection dysfunction. Review of the literature. Actas Urol Esp. 1992;16(3):208-16.
2. Floth A, Schramek P. Intracavernous injection of prostaglandin E1 in combination with papaverine: enhanced effectiveness in comparison with papaverine plus phentolamine and prostaglandin E1 alone. J Urol. 1991;145(1):56-9.
3. Gushchin IS. Effect of prostaglandin E1 and papaverine on anaphylactic histamine liberation from mast cells. Patol Fiziol Eksp Ter. 1977;1:32-5.
4. Gushchin IS, Fredkhol'm B, Uvnas B. Effect of papaverine and prostaglandin E1 on preparation /48/80-induced histamine liberation from rat mast cells. Patol Fiziol Eksp Ter. 1975;6:3-7.
Submetido em:
20/10/2022
Aceito em:
28/11/2022
